scholarly journals Single vocal cord irradiation: A competitive treatment strategy in early glottic cancer

2011 ◽  
Vol 101 (3) ◽  
pp. 415-419 ◽  
Author(s):  
Peter C. Levendag ◽  
David N. Teguh ◽  
Fatma Keskin-Cambay ◽  
Abrahim Al-Mamgani ◽  
Peter van Rooij ◽  
...  
2012 ◽  
Vol 103 ◽  
pp. S178
Author(s):  
P. Levendag ◽  
D.N. Teguh ◽  
P. Janssen ◽  
F. Keskin-Cambay ◽  
P. van Rooij ◽  
...  

2011 ◽  
Vol 47 ◽  
pp. S561
Author(s):  
P. Levendaq ◽  
D.N. Teguh ◽  
F. Keskin-Cambay ◽  
S.L.S. Kwa ◽  
P. Rooij van ◽  
...  

2012 ◽  
Vol 103 ◽  
pp. S354-S355
Author(s):  
S.L.S. Kwa ◽  
S.O.S. Osman ◽  
A. Al-Mamgani ◽  
A. Gangsaas ◽  
B.J.M. Heijmen ◽  
...  

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Houda Bahig ◽  
David I. Rosenthal ◽  
Félix-Phuc Nguyen-Tan ◽  
David C. Fuller ◽  
Ying Yuan ◽  
...  

Abstract Background Radiotherapy, along with laser surgery, is considered a standard treatment option for patients with early glottic squamous cell cancer (SCC). Historically, patients have received complete larynx radiotherapy (CL-RT) due to fear of swallowing and respiratory laryngeal motion and this remains the standard approach in many academic institutions. Local control (LC) rates with CL-RT have been excellent, however this treatment can carry significant toxicities include adverse voice and swallowing outcomes, along with increased long-term risk of cerebrovascular morbidity. A recent retrospective study reported improved voice quality and similar local control outcomes with focused vocal cord radiotherapy (VC-RT) compared to CL-RT. There is currently no prospective evidence on the safety of VC-RT. The primary objective of this Bayesian Phase II trial is to compare the LC of VC-RT to that of CL-RT in patients with T1N0 glottic SCC. Methods One hundred and fifty-five patients with T1a-b N0 SCC of the true vocal cords that are n ot candidate or declined laser surgery, will be randomized in a 1:3 ratio the control arm (CL-RT) and the experimental arm (VC-RT). Randomisation will be stratified by tumor stage (T1a/T1b) and by site (each site will be allowed to select one preferred radiation dose regimen, to be used in both arms). CL-RT volumes will correspond to the conventional RT volumes, with the planning target volume extending from the top of thyroid cartilage lamina superiorly to the bottom of the cricoid inferiorly. VC-RT volumes will include the involved vocal cord(s) and a margin accounting for respiration and set-up uncertainty. The primary endpoint will be LC at 2-years, while secondary endpoints will include patient-reported outcomes (voice impairment, dysphagia and symptom burden), acute and late toxicity radiation-induced toxicity, overall survival, progression free survival, as well as an optional component of acoustic and objective measures of voice analysis using the Consensus Auditory-Perceptual Evaluation of Voice. Discussion This study would constitute the first prospective evidence on the efficacy and safety of VC-RT in early glottic cancer. If positive, this study would result in the adoption of VC-RT as standard approach in early glottic cancer. Trial registration ClinicalTrials.gov Identifier: NCT03759431 Registration date: November 30, 2018


Head & Neck ◽  
2019 ◽  
Vol 42 (5) ◽  
pp. 854-859 ◽  
Author(s):  
Seung Yeun Chung ◽  
Chang Geol Lee

Author(s):  
Su Hyun Ahn ◽  
Jun Hyun Kim ◽  
Su Hyun Lee ◽  
Woo Jin Kim ◽  
Dong-Hoon Kim ◽  
...  

Author(s):  
Lucia Staníková ◽  
Karol Zeleník ◽  
Martin Formánek ◽  
Jana Seko ◽  
Radana Walderová ◽  
...  

Abstract Purpose To evaluate voice quality evolution after a transoral laser cordectomy (TLC) for precancerous lesions and early glottic cancer. Methods This prospective study enrolled 18 patients scheduled for TLC for high-grade dysplasia, Tis, T1, and T2 glottic squamous cell cancers, from May 2017 to March 2020. Patients were grouped according to the extent of TLC: Group I (n = 11, 61.1%): unilateral subepithelial or subligamental cordectomy; Group II (n = 7, 38.9%): unilateral transmuscular, total, or extended cordectomy. Voice quality parameters, including dysphonia grade (G), roughness (R), breathiness (B), maximal phonation time (MPT), jitter, and shimmer, were evaluated before, and at 6 weeks and 6 months after the TLC. Results In Group I, the degree of G and R items remained without substantial improvement 6 weeks after surgery; however, improved above the pre-surgery level up to 6 months after surgery. The MPT, jitter, and shimmer did not change significantly at 6 weeks or 6 months post-TLC. In Group II, G, R, and B remained significantly impaired even 6 months post-surgery. Jitter, and shimmer worsened at 6 weeks, but reached preoperative levels at 6 months post-surgery. MPT was significantly worse at 6 weeks and remained deteriorated at 6 months post-surgery. All measured parameters were significantly worse in Group II than in Group I at 6 weeks and 6 months post-surgery. No patient required a phonosurgical procedure. Conclusion After a TLC, voice quality evolution depended on the extent of surgery. It did not improve at 6 weeks post-surgery. Improvements in less extent cordectomies occurred between 6 weeks and 6 months post-surgery. Understanding voice development over time is important for counseling patients when considering phonosurgical procedures.


Sign in / Sign up

Export Citation Format

Share Document